rs199545183
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_004446.3(EPRS1):c.4456C>T(p.Leu1486Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000139 in 1,614,132 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L1486L) has been classified as Likely benign.
Frequency
Consequence
NM_004446.3 missense
Scores
Clinical Significance
Conservation
Publications
- leukodystrophy, hypomyelinating, 15Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152202Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000131 AC: 33AN: 250958 AF XY: 0.000118 show subpopulations
GnomAD4 exome AF: 0.000143 AC: 209AN: 1461812Hom.: 1 Cov.: 32 AF XY: 0.000155 AC XY: 113AN XY: 727212 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74502 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.4456C>T (p.L1486F) alteration is located in exon 32 (coding exon 32) of the EPRS gene. This alteration results from a C to T substitution at nucleotide position 4456, causing the leucine (L) at amino acid position 1486 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 1486 of the EPRS protein (p.Leu1486Phe). This variant is present in population databases (rs199545183, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with EPRS-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at